These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17352682)

  • 1. Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.
    Van der Veken P; Haemers A; Augustyns K
    Curr Top Med Chem; 2007; 7(6):621-35. PubMed ID: 17352682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein.
    Chen SJ; Jiaang WT
    Curr Top Med Chem; 2011; 11(12):1447-63. PubMed ID: 21510839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.
    Rosenblum JS; Kozarich JW
    Curr Opin Chem Biol; 2003 Aug; 7(4):496-504. PubMed ID: 12941425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.
    Lankas GR; Leiting B; Roy RS; Eiermann GJ; Beconi MG; Biftu T; Chan CC; Edmondson S; Feeney WP; He H; Ippolito DE; Kim D; Lyons KA; Ok HO; Patel RA; Petrov AN; Pryor KA; Qian X; Reigle L; Woods A; Wu JK; Zaller D; Zhang X; Zhu L; Weber AE; Thornberry NA
    Diabetes; 2005 Oct; 54(10):2988-94. PubMed ID: 16186403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation.
    Han R; Wang X; Bachovchin W; Zukowska Z; Osborn JW
    Sci Rep; 2015 Aug; 5():12348. PubMed ID: 26242871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression pattern of dipeptidyl peptidase IV activity and/or structure homologues in cancer.
    Kotacková L; Baláziová E; Sedo A
    Folia Biol (Praha); 2009; 55(3):77-84. PubMed ID: 19545486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
    Juillerat-Jeanneret L
    J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    Thornberry NA; Weber AE
    Curr Top Med Chem; 2007; 7(6):557-68. PubMed ID: 17352677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of a propeller loop in the quaternary structure and enzymatic activity of prolyl dipeptidases DPP-IV and DPP9.
    Tang HK; Chen KC; Liou GG; Cheng SC; Chien CH; Tang HY; Huang LH; Chang HP; Chou CY; Chen X
    FEBS Lett; 2011 Nov; 585(21):3409-14. PubMed ID: 22001206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects.
    Liu Y; Hu Y; Liu T
    Curr Med Chem; 2012; 19(23):3982-99. PubMed ID: 22709010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein.
    Tsai TY; Yeh TK; Chen X; Hsu T; Jao YC; Huang CH; Song JS; Huang YC; Chien CH; Chiu JH; Yen SC; Tang HK; Chao YS; Jiaang WT
    J Med Chem; 2010 Sep; 53(18):6572-83. PubMed ID: 20718420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries.
    Matheeussen V; Baerts L; De Meyer G; De Keulenaer G; Van der Veken P; Augustyns K; Dubois V; Scharpé S; De Meester I
    Biol Chem; 2011 Mar; 392(3):189-98. PubMed ID: 21194356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues.
    Roppongi S; Suzuki Y; Tateoka C; Fujimoto M; Morisawa S; Iizuka I; Nakamura A; Honma N; Shida Y; Ogasawara W; Tanaka N; Sakamoto Y; Nonaka T
    Sci Rep; 2018 Feb; 8(1):2714. PubMed ID: 29426867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, structure-activity relationships, and docking studies of 1-(γ-1,2,3-triazol substituted prolyl)-(S)-3,3-difluoropyrrolidines as a novel series of potent and selective dipeptidyl peptidase-4 inhibitors.
    Zhang L; Su M; Li J; Ji X; Wang J; Li Z; Li J; Liu H
    Chem Biol Drug Des; 2013 Feb; 81(2):198-207. PubMed ID: 22994702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases.
    Qi SY; Riviere PJ; Trojnar J; Junien JL; Akinsanya KO
    Biochem J; 2003 Jul; 373(Pt 1):179-89. PubMed ID: 12662155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous (19)F NMR screening of prolyl oligopeptidase and dipeptidyl peptidase IV inhibitors.
    Kichik N; Tarragó T; Giralt E
    Chembiochem; 2010 May; 11(8):1115-9. PubMed ID: 20397181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes.
    Drucker DJ
    Expert Opin Investig Drugs; 2003 Jan; 12(1):87-100. PubMed ID: 12517256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prolyl-aminodipeptidases and their inhibitors as therapeutic targets for fibrogenic disorders.
    Juillerat-Jeanneret L; Gerber-Lemaire S
    Mini Rev Med Chem; 2009 Feb; 9(2):215-26. PubMed ID: 19200026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening.
    Ojeda-Montes MJ; Gimeno A; Tomas-Hernández S; Cereto-Massagué A; Beltrán-Debón R; Valls C; Mulero M; Pujadas G; Garcia-Vallvé S
    Med Res Rev; 2018 Sep; 38(6):1874-1915. PubMed ID: 29660786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.